Benicar Side Effects. What are the side effects of the high blood pressure drug olmesartan (trade names: Benicar in the US, Olmetec in EU and Canada, WinBP and Golme in India, and Erastapex in Egypt)? The National Library of Medicine lists dizziness, swelling, hoarseness, and breathing/swallowing difficulty as the most common side effects. However, a new study by Mayo Clinic gastroenterologist Dr. Joseph Murray found that some patients who took the drug reported gastrointestinal disorders […]
Benzocaine Side Effects. Benzocaine, a topical pain reliever usually applied to the gums or the mouth to soothe pain, can be dangerous to your health. According to the U.S. Food and Drug Administration, use of Benzocaine — which is found in over-the-counter drugs such as Anbesol, Hurricaine, Orajel, Baby Orajel, Orabase, Americaine, and many others — can lead “to a rare but serious—and sometimes fatal—condition called methemoglobinemia”. Metheglobinemia leads to a reduction in the amount […]
Spinraza Side Effects. Last month, the Food and Drug Administration (FDA) approved the use of Spinraza as the first ever drug to “treat children and adults with spinal muscular atrophy”.
Invokana Side Effects: Kidney Damage, UTI, and Ketoacidosis. What are the Invokana side effects that patients using the Type 2 diabetes drug should be aware of? The more common side effects include the following: urinary tract infections increased urination yeast infections vaginal itching thirst constipation nausea fatigue weakness skin sensitivity to sunlight and hypersensitivity reactions (including skin redness, rash, itching, hives, and swelling) bladder pain bloody or cloudy urine decreased frequency or amount of urine […]
Taltz Side Effects. People with psoriasis have an alternative drug in the form of Taltz which was approved by the Food and Drug Administration early this year. Does it work? Well, clinical trials prove that it does. From fda.gov: Taltz’s safety and efficacy were established in three randomized, placebo-controlled clinical trials with a total of 3,866 participants with plaque psoriasis who were candidates for systemic or phototherapy therapy. The results showed that Taltz achieved greater […]